Viva Big Pharma

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Regardless of what happens from here on out, the current health care reform clearly will offer no significant challenge to Big Pharma, which year after year rates among the top two or three most profitable industries in the world. This leaves the drug manufacturers free to carry out their vital, life-saving work. One example of that work appears today on John Mack’s highly informative Pharma Marketing Blog:

A Long Island man infringed on Pfizer’s trademark by towing a 20-foot replica missile with ‘Viva Viagra’ painted on its side through midtown Manhattan, eventually parking it in front of the drugmaker’s 42nd Street headquarters, a federal judge ruled.

This story dates back to last year, when a couple of guys from the Island came up with the rather kooky idea of using decommissioned military ordinance as an advertising medium. According to their web site, their company, Jet Angel, “takes the target marketing capabilities of mobile billboards and adds an experience for consumers to achieve the ultimate viewer captivation”—in other words, everyone is guaranteed to look at a giant missile being towed through the streets.

 

Apparently seeking to prove this claim, they emblazoned a missile with the slogan from Pfizer’s grotesque “Viva Viagra” ads, drove it around Manhattan, and hung out for a while in front of the drugmaker’s corporate headquarters. They followed up with an email to Pfizer:

Jet Angel hopes that you enjoyed yesterday’s visit to NYC including all your free PR. It is the intention to make a second trip next week, with the VIAGRA Missile, and ‘riding’ on top will be two models handing out free condoms!

LOOK AT ALL THE PEOPLE STARRING, THE JOY, THE IMPRESSIONS!!!!

Pfizer quickly sued the missile-launchers. (When the court issued a preliminary injunction, the feisty guys at Jet Angel returned to Pfizer HQ with the missile repainted to say “CENSORED BY A FEDERAL COURT.”) A spokesperson told the Wall Street Journal’s Law Blog that the company felt it was “important to protect the integrity of our medicines.”

 

Apparently, Pfizer believed the ”integrity” of the pioneering boner drug, which had weathered the company’s own creepy advertising campaigns (not to mention ED spokesmodel Bob Dole) would be harmed by what John Mack called the “erectile projectile.” The court agreed, and has now ruled in Pfizer’s favor, saying “Defendants’ midday sojourn with a missile to Pfizer’s world headquarters traded on the fame and reputation of Viagra.”

 

Big Pharma has long claimed that it has to charge high prices for its products so that it can continue its research and development work, discovering new drugs that will save lives and serve humanity. In fact, as Marcia Angell and others have thoroughly documented, a larger percentage of the industry’s revenues goes to profits than to R&D–and an even larger portion goes to “marketing and administration,” which includes not only myriad campaigns to promote the costly drugs, but also legal fees to launch ridiculous lawsuits like this one. 

 

In other words, every time you buy a Pfizer drug, the company puts a fraction of the proceeds toward defending its reputation against things like penis-shaped missiles on wheels. And there’s nothing in the current health care reform that will throw that mission off course.

 

viagra-missile_thumbnail

 

This post also appears on James Ridgeway’s blog, Unsilent Generation.

THE FACTS SPEAK FOR THEMSELVES.

At least we hope they will, because that’s our approach to raising the $350,000 in online donations we need right now—during our high-stakes December fundraising push.

It’s the most important month of the year for our fundraising, with upward of 15 percent of our annual online total coming in during the final week—and there’s a lot to say about why Mother Jones’ journalism, and thus hitting that big number, matters tremendously right now.

But you told us fundraising is annoying—with the gimmicks, overwrought tone, manipulative language, and sheer volume of urgent URGENT URGENT!!! content we’re all bombarded with. It sure can be.

So we’re going to try making this as un-annoying as possible. In “Let the Facts Speak for Themselves” we give it our best shot, answering three questions that most any fundraising should try to speak to: Why us, why now, why does it matter?

The upshot? Mother Jones does journalism you don’t find elsewhere: in-depth, time-intensive, ahead-of-the-curve reporting on underreported beats. We operate on razor-thin margins in an unfathomably hard news business, and can’t afford to come up short on these online goals. And given everything, reporting like ours is vital right now.

If you can afford to part with a few bucks, please support the reporting you get from Mother Jones with a much-needed year-end donation. And please do it now, while you’re thinking about it—with fewer people paying attention to the news like you are, we need everyone with us to get there.

payment methods

THE FACTS SPEAK FOR THEMSELVES.

At least we hope they will, because that’s our approach to raising the $350,000 in online donations we need right now—during our high-stakes December fundraising push.

It’s the most important month of the year for our fundraising, with upward of 15 percent of our annual online total coming in during the final week—and there’s a lot to say about why Mother Jones’ journalism, and thus hitting that big number, matters tremendously right now.

But you told us fundraising is annoying—with the gimmicks, overwrought tone, manipulative language, and sheer volume of urgent URGENT URGENT!!! content we’re all bombarded with. It sure can be.

So we’re going to try making this as un-annoying as possible. In “Let the Facts Speak for Themselves” we give it our best shot, answering three questions that most any fundraising should try to speak to: Why us, why now, why does it matter?

The upshot? Mother Jones does journalism you don’t find elsewhere: in-depth, time-intensive, ahead-of-the-curve reporting on underreported beats. We operate on razor-thin margins in an unfathomably hard news business, and can’t afford to come up short on these online goals. And given everything, reporting like ours is vital right now.

If you can afford to part with a few bucks, please support the reporting you get from Mother Jones with a much-needed year-end donation. And please do it now, while you’re thinking about it—with fewer people paying attention to the news like you are, we need everyone with us to get there.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate